Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

Not specified

Conditions
HIV InfectionsHistoplasmosis
Trial Locations (13)

10016

Bellevue Hosp / New York Univ Med Ctr, New York

29169

Julio Arroyo, West Columbia

30308

Emory Univ, Atlanta

46202

Methodist Hosp of Indiana / Life Care Clinic, Indianapolis

Wishard Hosp, Indianapolis

60612

Cook County Hosp, Chicago

75390

Univ of Texas, Southwestern Med Ctr of Dallas, Dallas

432101228

Ohio State Univ Hosp Clinic, Columbus

452670405

Univ of Cincinnati, Cincinnati

462025250

Indiana Univ Hosp, Indianapolis

681985130

Univ of Nebraska Med Ctr, Omaha

900331079

Univ of Southern California / LA County USC Med Ctr, Los Angeles

941104206

University of California San Francisco, San Francisco

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00006316 - Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs | Biotech Hunter | Biotech Hunter